Japan Investigational New Drug CDMO Market (2025-2031) | Outlook, Forecast, Share, Analysis, Companies, Competitive Landscape, Trends, Value, Industry, Segmentation, Size & Revenue, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Japan Country Macro Economic Indicators

3.2 Japan Investigational New Drug CDMO Market Revenues & Volume, 2021 & 2031F

3.3 Japan Investigational New Drug CDMO Market - Industry Life Cycle

3.4 Japan Investigational New Drug CDMO Market - Porter's Five Forces

3.5 Japan Investigational New Drug CDMO Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 Japan Investigational New Drug CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F

3.7 Japan Investigational New Drug CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for novel drug development in Japan

4.2.2 Rise in outsourcing of drug development activities by pharmaceutical companies

4.2.3 Favorable regulatory environment supporting investigational new drug (IND) development

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for IND approval in Japan

4.3.2 High costs associated with drug development and manufacturing

4.3.3 Limited availability of skilled workforce in the CDMO sector

6.1 Japan Investigational New Drug CDMO Market, By Product

6.1.1 Overview and Analysis

6.1.2 Japan Investigational New Drug CDMO Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 Japan Investigational New Drug CDMO Market Revenues & Volume, By Small Molecule, 2021- 2031F

6.1.4 Japan Investigational New Drug CDMO Market Revenues & Volume, By Large Molecule, 2021- 2031F

6.2 Japan Investigational New Drug CDMO Market, By Service

6.2.1 Overview and Analysis

6.2.2 Japan Investigational New Drug CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F

6.2.3 Japan Investigational New Drug CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F

6.3 Japan Investigational New Drug CDMO Market, By End-user

6.3.1 Overview and Analysis

6.3.2 Japan Investigational New Drug CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F

6.3.3 Japan Investigational New Drug CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F

6.3.4 Japan Investigational New Drug CDMO Market Revenues & Volume, By Others, 2021- 2031F

7.1 Japan Investigational New Drug CDMO Market Export to Major Countries

7.2 Japan Investigational New Drug CDMO Market Imports from Major Countries

8.1 Average time taken for IND approval in Japan

8.2 Number of new drug development projects outsourced to CDMOs

8.3 Percentage of successful IND submissions in Japan

8.4 Utilization rate of manufacturing facilities in the CDMO sector

8.5 Number of collaborations between CDMOs and pharmaceutical companies in Japan

9.1 Japan Investigational New Drug CDMO Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 Japan Investigational New Drug CDMO Market Opportunity Assessment, By Service, 2021 & 2031F

9.3 Japan Investigational New Drug CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 Japan Investigational New Drug CDMO Market Revenue Share, By Companies, 2024

10.2 Japan Investigational New Drug CDMO Market Competitive Benchmarking, By Operating and Technical Parameters